Zusammenfassung
Es wird eine praxisrelevante Übersicht zu den Risiken von Psychopharmaka in Schwangerschaft und Stillzeit gegeben. Sehr ausführlich wird das Risiko von Antidepressiva besprochen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Boukhris T, Sheehy O, Mottron L, Bérard A (2016) Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr 170(2): 117–124
Bromley R, Weston J, Adab N et al (2014) Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev 10: CD010236
Bruning AHL, Heller HM, Kieviet N et al (2015) Antidepressants during pregnancy and postpartum hemorrhage: a systematic review. Eur J Obstet Gynecol Reprod Biol 189: 38–47
Campbell E, Kennedy F, Russell A et al (2014) Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J Neurol Neurosurg Psychiatry 85(9): 1029–1034
Cohen LS, Viguera AC, McInerney KA et al (2016) Reproductive safety of second-generation antipsychotics: current data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Am J Psychiatry 173(3): 263–270
Deiana V, Chillotti C, Manchia M et al (2014) Continuation versus discontinuation of lithium during pregnancy: a retrospective case series. J Clin Psychopharmacol 34(3): 407–410
Dennis CL, Dowswell T (2013) Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression. Cochrane Database Syst Rev 7: CD006795
Diav-Citrin O, Shechtman S, Tahover E (2014) Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Am J Psychiatry 171(7): 785–794
DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (Hrsg) für die Leitliniengruppe Unipolare Depression (2015) S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, 2. Aufl. Version 2. www.depression.versorgungsleitlinien.de (Online-Zugriff: 10.03.2016)
Furu K, Kieler H, Haglund B et al (2015) Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ 350: h1798
Grigoriadis S, Vonderporten EH, Mamisashvili L et al (2014) Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ 348: f6932
Hanley GE, Smolina K, Mintzes B et al (2016) Postpartum hemorrhage and use of serotonin reuptake inhibitor antidepressants in pregnancy. Obstet Gynecol 127(3): 553–561
Huybrechts KF, Palmsten K, Avorn J et al (2014) Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med 370: 2397–2407
Huybrechts KF, Bateman BT, Palmsten K et al (2015) Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA 313(21): 2142–2151
Jimenez-Solem E, Andersen JT, Petersen M et al (2013) SSRI use during pregnancy and risk of stillbirth and neonatal mortality. Am J Psychiatry 170(3): 299–304
Kieler H, Artama M, Engeland A et al (2012) Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 344: d8012
Klinger G, Stahl B, Fusar-Poli P, Merlob P (2013) Antipsychotic drugs and breastfeeding. Pediatr Endocrinol Rev 10(3): 308–317
Larrimer MB, Dajani NK, Siegel ER et al (2014) Antiemetic medications in pregnancy: a prospective investigation of obstetric and neurobehavioral outcomes. Am J Obstet Gynecol 210(3): 270.e1–7
Leiknes KA, Cooke MJ, Jarosch-von Schweder L et al (2015) Electroconvulsive therapy during pregnancy: a systematic review of case studies. Arch Womens Ment Health 18(1): 1–39
Meador KJ, Baker GA, Browning N et al (2014) Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr 168(8): 729–736
Minozzi S, Amato L, Bellisario C et al (2013) Maintenance agonist treatments for opiate-dependent pregnant women. Cochrane Database Syst Rev 12: CD006318
O’Hara MW, McCabe JE (2013) Postpartum depression: current status and future directions. Annu Rev Clin Psychol 9: 379–407
Polen KN, Rasmussen SA, Riehle-Colarusso T, Reefhuis J; National Birth Defects Prevention Study (2013) Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997–2007. Birth Defects Res A Clin Mol Teratol 97(1): 28–35
Reefhuis J, Devine O, Friedman JM et al (2015) Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports. BMJ 351:h3190
Ross LE, Grigoriadis S, Mamisashvili L et al (2013) Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry 70(4): 436–443
Smit M, Dolman KM, Honig A (2016) Mirtazapine in pregnancy and lactation – a systematic review. Eur Neuropsychopharmacol 26(1): 126–135
Tomson T, Battino D, Perucca E (2015) Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. Lancet Neurol pii: S1474-4422(15)00314-2
van der Lugt NM, van de Maat JS, van Kamp IL et al (2012) Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies. Early Hum Dev 88(6): 375–378
Wemakor A, Casson K, Garne E et al (2015) Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study. Eur J Epidemiol 30(11): 1187–1198
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Paulzen, M., Benkert, O. (2017). Psychopharmaka in Schwangerschaft und Stillzeit. In: Benkert, O., Hippius, H. (eds) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50333-1_14
Download citation
DOI: https://doi.org/10.1007/978-3-662-50333-1_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-50332-4
Online ISBN: 978-3-662-50333-1
eBook Packages: Medicine (German Language)